ArticleInternational journal of molecular sciences2019

EGFR-Specific Tyrosine Kinase Inhibitor Modifies NK Cell-Mediated Antitumoral Activity against Ovarian Cancer Cells.

Nina Mallmann-Gottschalk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.